Discontinued Other versions of this medicine may still be available. Information for reference purposes.
- Active Ingredients
Product Documentation
-
View RMM (Agomelatine Patient Information)
Last updated on this site: 20 Sep 2022
Initial upload
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintDiscontinued Other versions of this medicine may still be available. Information for reference purposes.
Agomelatine Accord 25mg Film-coated Tablets
- PL Number:
- 20075/1241
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Discontinued
Product Documentation
-
View Patient Information Leaflet (PIL- Agomelatine Accord 25mg Film-coated Tablets)
Last updated on this site: 24 May 2023
PIL missing, added during APS audit
View Summary of Product Characteristics (SmPC - Agomelatine Accord 25mg Film-coated Tablets)Last updated on this site: 17 Apr 2023
Variation description: An unlimited MA has been granted. 3 yearly PSURs will be submitted as per the EURD list if required.
SmPC sections updated – 9 and 10.
MHRA Renewal approval date – 14/04/2023
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.